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Infections with  group A  streptococci are  considered to  be  responsible  for 
the development of important structural and functional changes in the hearts 
of human beings and experimental animals  (1,  2), but the manner in which 
streptococcal infections bring  about  these  changes  remains  obscure.  Of  the 
diverse extracellular products elaborated during the growth of group A  strep- 
tococci, only  two---streptococcal proteinase  and  streptolysin  O--are  known 
to have an effect upon the heart. A single intravenous injection of crystalline 
streptococcal proteinase has been shown to cause focal necrosis of the myo- 
cardium in rabbits, mice, and guinea pigs (3); and solutions  containing strep- 
tolysin O have been found to induce systolic contracture of the isolated frog 
heart (4-6). The studies now to be presented demonstrate that a minute quan- 
tity of streptolysin O brings about a prompt and irreversible loss of myocardial 
contractile power when per[used through  the  isolated hearts  of guinea pigs, 
rabbits, and rats. 
Materials and Methods 
The general plan of the experiments was as follows. Hearts were removed 
from guinea pigs, rabbits, and rats, set up in a modified Langendorff apparatus, 
and per[used through the coronary arteries with an oxygenated salt solution 
containing  glucose.  The  rate  and  amplitude  of  contraction  were  recorded 
mechanically on a  moving paper strip, and the rate of perfusion was measured 
by means of a  flow-meter. While  the heart was  beating vigorously, varying 
amounts of streptolysin O, previously activated with cysteine, were introduced 
into the perfusion fluid, and the effects on the rate and amplitude of contrac- 
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tion  and  on  the  rate  of  perfusion  were  observed.  In  control  studies,  the  iso- 
lated  and  perfused  hearts  were  exposed  to  cysteine,  to  streptolysin 0  not  ac- 
tivated  with  cysteine,  and  to  streptolysin 0  the hemolytic  activity  of  which 
had been inhibited by means  of cholesterol or specific antibody. 
Animals.--Normal,  male, market-bought guinea pigs weighing 300 to 600 gin. were em- 
ployed in most experiments. A  small number of adult rabbits of mixed breed and a number 
of male white rats were also used. 
Isolation  and  Perfusion  Techn~ue.--The  animals were  anesthetized with  sodium  pento- 
barbital supplemented with ether when necessary. A catheter was tied into the trachea and 
positive pressure respiration was maintained when the chest was opened. Heparin, 5  rag./ 
kilo, was injected into the inferior vena cava to prevent blood coagulation. A glass cannula 
was inserted into the first portion of the aorta, and the heart was removed rapidly and set 
up in a  modified Langendorff perfusion apparatus according to the procedure described in 
detail by Garb, Penna, and Scriabine (7). A fine silk suture was passed through the apex of 
the heart; one end of the suture was tied to the heart, the other was carried over a  small 
pulley and attached to a writing lever which recorded on a paper strip moving at a constant 
rate of speed. The amplitude of contraction and the heart rate could thus be measured di- 
rectly from the tracing. Reduction in the amplitude of contraction was graded on an arbi- 
trary scale from 0 to ++++,  in which 0 represents no change from the baseline recording; 
+, up to 25 per cent reduction; ++,  25 to 50 per cent reduction; and +++  and  ++++, 
50 to 75 per cent, and more than 75 per cent reduction, respectively. 
The peffusion fluid employed had the following composition per liter: 
NaC1  7.0 gin. 
KC1,  0.42  " 
CaC12  0.24  " 
MgCI~,  0.2  " 
NaHC03, 2.1  " 
Dextrose, 1.8  " 
This fluid was also used as the diluent for all materials injected. The peffusion pressure in 
all experiments was 52 cm. of water. The temperature of the perfusion fluid was maintained 
at 37°C., and a  mixture of 95 per cent oxygen and 5 per cent carbon dioxide was bubbled 
continuously through the fluid. 
The rate of flow of perfusion fluid through the heart was measured at frequent intervals 
during each experiment by means of a  flow-meter incorporated in the apparatus.  Since the 
cannula was inserted into the aorta just above the aortic valve, it was to be expected that 
most of the fluid would flow  through the coronary arteries. To confirm this, an experiment 
was done in which a  guinea pig heart was isolated in the usual fashion, the inferior and su- 
perior venae cavae were ligated, and a catheter was tied into the pulmonary artery to collect 
the effluate from the right side of the heart. More than 97 per cent of the fluid peffused into 
the aortic cannuia escaped from the right side of the heart through the catheter in the pul- 
monary artery, the finding indicating that practically all the fluid passed through the coro- 
nary arteries and was discharged through the coronary sinus into the right auricle or through 
those Thebesian channels that empty into the right heart. It seems reasonable, therefore, to 
regard the rate of perfusion as a measure of coronary flow. 
All additions of streptolysin O  and other materials were made through a  fine polyviny] 
plastic catheter threaded through the apparatus and  ending in  the cannula about  1  inch 
above the heart. The total volume of the catheter was 0.5 ml. The outer end of the catheter 
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purposes. The volume of injected material was 2 ml. in all cases, and each injection was fol- 
lowed immediately by 0.7 ml. of peffusion fluid to flush out the catheter. The total injection 
time was about IS seconds.  It was estimated from the rate of perfuslon that all the injected 
material flowed through the heart within x~ to 2 minutes following injection. The peffusion 
fluid was not recirculated, and the exposure of the heart to the injected material was there- 
fore brief. 
Streptolysin  O.--Most  of the  experiments  to  be  described were  carried  out with  frac- 
donated culture supernates prepared from 15 liter cultures of the C203S  strain of group A 
streptococcus.  After growing the cocci according to  the  method  of Bemheimer,  Gillman, 
Hotfle, and Pappenheimer (8), the supemate was concentrated S- to 8-fold by pervaporation 
from cellophane sacs in the presence of a  small amount  of toluene. The concentrate was 
chilled, saturated with ammonium sulfate, and allowed to stand overnight in the cold. The 
resulting precipitate was collected on a  Buchner funnel and dissolved in a  small volume of 
cold water. The cloudy solution was dialyzed overnlght against x~mu{,g tap water and then 
centrifuged  to  remove  insoluble  material.  The  clear  supernate  was  dialyzed  in  the 
cold against 80 per cent saturated ammonium sulfate. To the resulting predpitate was added 
sufficient 80 per cent saturated  ammonium sulfate to bring the volume to  100  ml.,  or in 
some instances to 50 ml., after which the material was stored in the cold. As required, ali- 
quots were dialyzed free of ammonium sulfate, a  3- to 4-fold increase in volume occurring 
during dialysis. The dialyzed material was stable for 4 to S days when stored at 4°C. Four 
different lots of streptolysin O were employed in these studies. Their content of streptolysin 
O prior to dialysis ranged from 10,000 to 53,000 hemolytic units per ml. Hemolytic activity 
was measured  by the method  of Bernheimer  (9)  modified by preliminary activation with 
cystelne and by the inclusion of 0.1 per cent bovine serum albumin in the sallne-phosphate 
diluent. 
Unless otherwise indicated, the dialyzed streptolysin O preparation was activated imme- 
diately prior to use by adding an equal volume of peffusion fluid containing 1 per cent cys- 
teine and adjusted to pH 7.0. After 10 minutes at room temperature the mixture was diluted 
to  the  desired  concentration  of streptolysin  O,  using 0.1  per cent bovine serum  albumin 
(Armour)  in perfusion fluid as the diluent. The bovine serum albumin was added  in order 
to  stabilize the activity of dilute solutions of streptolysin O. In a  number  of preliminary 
experiments it was ascertained that neither cysteine in the concentration employed, nor 0.1 
per cent bovine serum albumin had any significant effect on the rate or amplitude of con- 
traction of the isolated peffused heart. 
EXPERIMENTAL 
Loss o.1 Contractile Force Induced in the Isolated  and Perfused Hearts of Guinea 
Pigs, Rabbits, and Rats by Solutions Containing Streptolysin 0 
A number of experiments were first done in which the isolated and peffused 
hearts  of guinea  pigs  were  exposed to  solutions  containing various  concen- 
trations of streptolysin O. All told, the hearts of nineteen normal guinea pigs 
were removed and set up in the peffusion apparatus; each was given a  single 
injection of streptolysin O in a dosage of 7.5 to 100 hemolytic units, diluted to 
2  ml.  in  peffusion fluid  containing  0.1  per  cent bovine serum  albumin.  In 
every instance  in  which  15  or more units  of streptolysin O  was  injected, a 
reduction in the contractile force of the heart, as evidenced by a  decrease in 
the amplitude of contraction, was noted within ~,~ to 2 minutes following in- 364  STREPTOLYSIN  O  IN  MP,  M~ALIAN  HEARTS 
jection.  The  amplitude  of  contraction  decreased  rapidly  and  progressively 
during  the  next  2  to  3  minutes,  and  the  contractions  ceased completely or 
nearly so usually within 5 minutes of the time of injection. In many cases there 
were  no  visible ventricular contractions whatever,  and  only a  few  flickering 
beats of the auricles could be seen upon  close examination of the heart.  The 
TABLE I 
Effec¢ of Solutions Containing Streptolysin 0  on the Isolated and Perfused Hearts of Normal 
Guinea Pigs 
























































* Streptolysin O was activated with cysteine just prior to use. All dilutions were made in 
0.1 per cent bovine serum albumin in the same fluid as was used for perfusion of the heart. 
Reduction in amplitude of contraction in this and in succeeding tables was graded on an 
arbitrary scale from 0 to -P-t-++, in which 0 represents no change;  -t-, up to 25  per cent 
reduction; ++,  25-50 per cent reduction; -{--{-+, 50-75 per cent reduction; and -t-+-t--}-, 
greater than 75 per cent reduction. 
The guinea pigs in this experiment weighed 300 to 425 gln. 
loss of contractile power induced by streptolysin O  was not spontaneously re- 
versible, for no recovery in the amplitude of contraction was observed even in 
those preparations in which perfusion was continued for as long as 75 minutes 
after injection. The  results of these experiments are summarized in Table I, 
and a  photograph of a  typical tracing is shown in Fig. 1. 
The rate of perfusion  through the coronary arteries decreased sharply following injection 
of streptolysin O, particularly in those cases in which large doses were given. The flow began KELLNER~ BEI~.I'~r~R~ CARLSON~ AND ]FREE'fAN  365 
to increase again within 1 to 2 minutes, and in many instances returned almost to the pre- 
injection levels within 5  minutes  (see  Fig. 2).  In no case,  however,  did  recovery of  con- 
tractile force accompany  the  reestablishment  of  coronary  flow.  The  relationship  between 
loss of contractility and reduced coronary flow will be considered in more detail further on. 
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FIG.  1. Photograph of a record showing the effect of a  solution containing streptolysin O 
on the amplitude of contraction of the isolated and peffused heart of a  normal guinea pig. 
Each division on the time scale represents one minute. 
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FIG. 2. The effect of a solution containing streptolysin 0  on the amplitude of contraction 
and rate of coronary flow of the isolated and perfused heart of a normal guinea pig. 
In some cases there was a  slight decrease in the heart rate, and occasionally also, arrhyth- 
mias  occurred;  these  changes  in  rate  and  rhythm  were  transitory,  however,  and  usually 
appeared  toward the end of the reaction, just before contractions ceased entirely. 366  STREPTOLYSIN  O  IN  MAMMALIAN  HEARTS 
In several experiments the isolated and perfused hearts of guinea pigs were given repeated 
small injections of streptolysin O in doses of 5 to l0 units each. The effects of  successive 
small doses upon the contractile force of the heart appeared to be cumulative, but the induc- 
tion of a substantial decrease in myocardial contractile force under these conditions required 
a larger total quantity of streptolysin O than had been observed in single dose experiments. 
A number of experiments were next performed in order to learn whether the 
effect of streptolysin 0  on myocardial contractility was limited to the guinea 
pig heart or whether the hearts of other mammals would be affected as well. 
TABLE  II 
E.ffea  of Solutions  Containing  Streptolysin  0  on the Isolated and Perfused  Hearts  of Normal 
Rabbits and Ra2s 




























* Streptolysin O was activated  with cysteine just prior to use and diluted in perfusion 
fluid containing 0.1 per cent bovine serum albumin. 
The rabbits in this experiment weighed 2,900 to 3,300 gin., and the rats, 275 to 500 gin. 
Accordingly, the hearts  of five normal rabbits,  and those  of seven normal white  rats, 
were removed and set up in the perfusion apparatus.  Each rabbit heart was exposed to a 
single injection of streptolysin O in a dose of 25 to 750 hemolytic units while each rat heart 
was exposed to 2 to 75 units. In every case, except with the smallest doses employed, there 
resulted prompt and striking reduction in the amplitude of contraction  (see Table II and 
Fig. 3), the sequence of events being almost precisely the same as that observed previously 
with the guinea pig hearts. The heart of an additional rat, not shown in the table, did not 
respond to 100 hemolytic units but underwent failure upon exposing it to a second dose of 
100 units. 
It was apparent from these studies that solutions containing streptolysin 0 
were extremely toxic to  the isolated perfused hearts of guinea pigs,  rabbits, KELLNER~  BERN'HEIMER,  CARLSON,  AND  FKEE~AN  367 
and rats, and that brief exposure of such hearts to relatively low concentrations 
of the lysin resulted in a striking reduction in contractile force. 
Evidence That the Cardiotoxic Factor Is Streptolysin 0 
The  streptolysin  0  solutions  employed in  the  foregoing  experiments,  al- 
though highly concentrated and purified to a considerable degree, were never- 
theless  known  to  contain  other  substances  in  addition  to  streptolysin  O. 
Studies were therefore undertaken to determine whether the active cardiotoxic 
principle was in fact streptolysin O, or some other agent, or agents, contained 
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FIG. 3. The effect of a  solution containing streptolysin O on the amplitude of contraction 
and the rate of coronary flow of the isolated and perfused heart of a  normal rat. 
in the solutions. In these investigations advantage was taken of the fact that 
the hemolytic activity of streptolysin  O  is known  to  require  activation  by 
cysteine or other sulfhydryl compounds, and  that  the hemolysin can be in- 
hibited by cholesterol and by sera containing specific antibody. 
AdivaJ~m by Cys~ne.--The hearts of two normal guinea pigs were removed and set up 
in the peffusion apparatus. One was exposed to 2 ml. of a  solution containing 750 units of 
streptolysin O  that had not been activated with cysteine; the other was given twice this 
dose, likewise unactivated. The only effect observed in either case was a  slight reduction in 
coronary flow.  Each heart was then given 2 ml. of a  solution containing 75 units of strep- 
tolysin O  activated with cysteine, and  loss of  contractile force ensued promptly  in  both 
cases (see Table It"I). Control experiments showed that cysteine alone in the concentrations 
used had no effect on the isolated heart. 
Inh~it~ by Choles~rol.--A fine suspension containing 1 rag. cholesterol per ml. was pre- 368  STREPTOLYSIN  0  IN  MAMMALIAN  IIEARTS 
pared according to the method of Cohen, Schwachman, and Perk/ns (10). To 4.5 ml. of the 
cholesterol suspension were  added  0.2  ml.  of cysteine-acfivated streptolysin O,  0.5  ml.  of 
I per cent bovine serum albumin, and 0.05 ml. of 1 per cent cysteine solution. Another mix- 
ture  identical with the  first  but lacking cholesterol was prepared  at  the same  time.  The 
amount of streptolysin O added in each case was such that the final concentration was 300 
hemolytic units in 2  ml. of the mixture.  Both mixtures were allowed to stand at 20°C.  for 
5 minutes; they were then centrifuged briefly and the clear supernates tested in the isolated 
and  perfused  hearts  of  two  guinea pigs.  The  solution  containing the  cholesterol-treated 
streptolysin was administered first and was found to have no effect on the amplitude of con- 
traction,  whereas  the  solution  containing  comparable  amounts  of  streptolysin  O  but  no 
cholesterol caused a  precipitous decrease in the amplitude of contraction within 2 to 3 min- 
TABLE  III 
Effect of Activation with Cysteine, and Incubation with Cholesterol and Specif~ Antibody on the 
Cardiotoxic A ction of Solutions Containing Streptolysin 0 
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* Streptolysin O was activated with cysteine unless specifically stated to the contrary. 
Antibody--horse antistreptolysin globulins, 20,000 units per ml., diluted to stated concen- 
tration in perfusion fluid. 
utes  (see Table III). It is of interest that the cholesterol-treated streptolysin O solution in 
each case caused a moderate reduction in the rate of coronary flow. 
Inhibitian  by  Antiserum.--Equal  parts  of  horse  aatistreptolysin  globulins  x diluted  to 
contain  20 Todd  antistreptolysin units per  ml.  (11)  and  a  solution  of  cysteine-activated 
streptolysin O containing 75 hemolytic units per ml. were mixed and permitted to stand at 
20°C.  for 5 minutes. Two ml. of this mixture administered to the isolated and perfused heart 
of a  normal guinea pig had no effect on the amplitude of contraction, though there was a 
moderate reduction in coronary flow.  This injection was then followed by 2  ml. containing 
75 units of the same streptolysin O solution but having no antibody. Reduction in amplitude 
of contraction ensued promptly (see Table III). In another experiment, 375 hemolytic units 
of streptolysin O incubated with 50 units of antibody was likewise found to be ineffective, 
but a  second injection containing 75 units of the same streptolysin O solution without anti. 
1 Antistreptolysin globulins, 20,000 units per ml. Batch No.  7,  19-9-47.  Serum Institute, 
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body caused a marked  decrease in contractile  force. In control  experiments, normal horse 
serum diluted to the same extent as the antibody preparation  did not interfere with the car- 
diotoxic activity of streptolysin O. 
Halbert, using agar diffusion techniques, has obtained evidence for the pres- 
ence  of  erythrogenic  toxin  in  the  concentrated  streptolysin  O  preparations 
used  in  these  studies  (12).  Hence  the  effect  of highly  purified  erythrogenic 
toxin  on  the  isolated  heart  was  investigated.  In  addition,  experiments  were 
done with streptolysin O produced by a group C streptococcus and with strep- 
tolysin O purified by electrochromatographic means. 
Erythrogcnic  Toxin.--The  erythrogenic  toxin,  kindly supplied by Dr.  A.  M.  Pappen- 
heimer, Jr., was prepared from Streptococcus pyogenes Strain 594]3 according to the method 
of Hottle and Pappenheimer  (13), and contained  one million skin test doses per ml. Ad- 
ministration of as much as 300,000 skin test units of erythrogenic toxin to the isolated guinea 
pig heart had no effect on the heart rate,  amplitude  of contraction,  or the rate of coronary 
flow. 
Other Streptolysin 0 Preparc~ions.--Streptoly~n O was obtained from a culture  of group 
C streptococcus,  Strain  H46A, according to the procedure  described by Rowen and Bern- 
heimer  (14); the streptolysin  O activity of the lot employed was  167,000 hemolytic  units 
per ml. In addition, streptolysin O from a culture of group A streptococcus was fractionated 
electrochromatographically  (15); the fraction  tested  had  15,000 hemolytic  units  per  ml. 
Both preparations  of streptolysin  O when injected into isolated guinea pig hearts in doses 
of 50 to 150 units caused a sharp decrease in amplitude  of contraction  and complete loss of 
contractile  force within  a  few minutes.  By contrast,  fractions  from the same electrochro- 
matographic separation which had no hemolytic activity had no effect on the isolated heart. 
It  is  evident  from  these  experiments  that  the  agent  responsible  for  the 
loss of contractile force of the isolated and perfused heart resembled streptoly- 
sin O in that it required prior activation with cysteine and it was inhibited com- 
pletely  by  cholesterol  and  by  specific  antibody.  Moreover,  streptolysin  O 
prepared  from a  group C  streptococcus and  streptolysin  O  fractionated  elec- 
trochromatographically were both active. Erythrogenic toxin, one of the known 
impurities  in the streptolysin O  solutions, was completely inactive. Taken to- 
gether,  the  findings  provide  strong  evidence  that  streptolysin  O  itself  is  the 
active cardiotoxic factor. 
The Effect on Coronary Flow of Solutions Containing Streptolysin 0 
The injection  of solutions  containing  streptolysin  O  into  the  isolated  and 
perfused hearts of guinea  pigs, rabbits,  and rats was followed in almost every 
case by a sharp drop in the rate of coronary flow, often to zero. In some cases, 
particurarly when larger doses of streptolysin O  were given, the coronary flow 
dropped  precipitously  to  zero  and  remained  there.  In most  cases,  however, 
the reduction was transitory,  lasting but a  minute or two; the flow then rose 
progressively,  but  did  not quite  reach  the preinjection levels (Figs.  2  and 3). 
There appeared  to be no direct relationship  between  the reduction in rate of 370  STREPTOI,YSIN  O  IN  M.~M'M'ALIAN HEARTS 
coronary flow and the reduction in the amplitude of contraction, for in those 
instances in  which  the  coronary flow returned  toward normal  there was  no 
corresponding  increase  in  the  amplitude  of  cardiac  contraction.  Moreover, 
a  moderate drop in coronary flow also occurred when the cardiotoxic action 
of streptolysin O  was inhibited by cholesterol or by antiserum even though 
there was no reduction in the amplitude of contraction. In order to obtain fur- 
ther evidence that the effect of streptolysin O solutions on ventricular contrac- 
tility was not secondary to the reduction in coronary flow, several experiments 
were carried out in which the flow of perfusion fluid to the isolated heart was 
damped off completely for 5 minutes and the effect on contractile force studied. 
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Fro. 4. The effect of damping off the coronary flow completely for 5 minutes on the am- 
plitude  of contraction of the isolated and perfused heart of a  normal guinea pig. 
The amplitude of contraction declined progressively following application of 
the clamp, and contractions ceased entirely within 2 to 3 minutes. When the 
clamp was released, however, the contractions resumed immediately, and the 
amplitude  of  contractions  increased  rapidly,  always  attaining  the  baseline 
level and sometimes even exceeding it. An example of such an experiment is 
given in Fig. 4. In the case of the streptolysin O injections, by contrast, in no 
instance was there comparable recovery of amplitude of ventricular contrac- 
tion despite the return of coronary flow almost to the preinjection level. The 
observations suggest that solutions of streptolysin O contain one or more sub- 
stances  that  are  capable of causing marked  spasm  of the  coronary arteries. 
This effect, however, appears to be independent of the effect of streptolysin O 
on cardiac contraction. 
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DISCUSSION 
Streptococcal preparations such as those employed in these studies are known 
to contain a number of high molecular weight substances not all of which have 
been isolated and identified. Among these substances is an agent here shown 
to bring about striking loss of myocardial contractile power when perfused 
through the isolated hearts of guinea pigs, rabbits, and rats. This agent is non- 
dialyzable, requires  activation by  the  sulfhydryl compound cysteine, is  in- 
hibited by a small amount of cholesterol, and is neutralized by antistreptolysin 
globulins but not by normal serum. The only extracellular product of strep- 
tococcal growth known to possess all these properties is the oxygen-labile he- 
molysin, streptolysin O.  Furthermore, four different batches  of streptolysin 
O having widely different hemolytic activities were found to have the same 
effect on the isolated and perfused heart when diluted to the same number of 
hemolytic units.  Finally, studies of streptolysin O  preparations  fractionated 
electrochromatographically showed  that  those  fractions having  streptolysin 
O activity brought about loss of contractile power of the isolated heart, whereas 
those devoid of streptolysin O  activity were not effective in this regard.  It 
can therefore be concluded that the agent affecting contractility of the myo- 
cardium is either streptolysin O  or a  substance indistinguishable from it by 
present criteria. 
The effect of streptolysin O on the mammalian heart as here demonstrated 
differed in one important respect from that on the frog heart noted in pre- 
vious investigations (4, 5). Toxicity for the frog heart was evident only when 
the streptococcal preparation was admiuistered in two doses.  The first dose 
released an inhibitor from the heart, while the second acted on the heart, now 
deprived of its inhibitor, to cause systolic standstill. In experiments with guinea 
pig hearts, it was never possible to demonstrate a requirement for two adminis- 
trations of streptolysin O  even though a  number of attempts to do so were 
carried out by repeatedly exposing the same heart to subtoxic concentrations. 
The guinea pig heart therefore appears to differ from that of the amphibian in 
lacking a  protective  inhibitor against  the  action of  the  toxin. 
The major effect of streptolysin O observed in these studies was a  striking 
and irreversible reduction in the force of cardiac contraction, indicating that 
the site of action was primarily the heart muscle itself. Whether this reduction 
in  myocardial contractile force comes about because  of interference with a 
metabolic pathway essential for the production of energy, or by alteration of 
cell membranes, or by changes in the contractile elements within the muscle, 
or by other means cannot be determined at the present time. In addition to 
their effect on the myocardium, the solutions injected caused a marked though 
transitory decrease in the rate of coronary flow. It is likely that the solutions 
contained one or more agents, besides streptolysin O, capable of inducing spasm 
of the coronary arteries;  for slight to moderate reductions in coronary flow 372  STR.EPTOLYSIN  0  IN M~M~rkLIAN  HEARTS 
were also observed in those experiments in which streptolysin O was inhibited 
by cholesterol or by specific antibody. 
It is noteworthy that administration to the isolated guinea pig or rat heart 
of solutions containing as little as 15 hemolytic units of streptolysin 0  caused 
unequivocal manifestations  of toxicity.  Since  15  hemolytic units  represents 
not more, and probably considerably less,  than  1 gg.  of streptolysin O, and 
since the period of time for the test material to traverse the heart was brief- 
some  30  to  120  seconds-it  is  evident  that  streptolysin  0  is  an  exceedingly 
potent cardiotoxic agent. 
SU]KMARY 
When solutions containing minute quantities of streptolysin O, previously 
activated with cysteine, were added to a  salt and glucose medium that was 
being peffused by way of the coronary arteries through the vigorously beating 
isolated hearts of guinea pigs, rabbits, and rats, the amplitude of myocardial 
contraction decreased abruptly, often to zero. The effect was usually accom- 
panied by a diminution in the flow of perfusion fluid, probably owing to spasm 
of the coronary arteries. The diminution in coronary flow was transitory, how- 
ever, lasting as a rule only 2 or 3 minutes, while the loss of myocardial contrac- 
tile power was permanent and irreversible. No decrease in myocardial contrac- 
tility was obtained when the streptolysin O was not previously activated with 
cysteine, or when the streptolysin O  was inhibited by cholesterol or by spe- 
cific antibody, the findings pointing to streptolysin O  as the active cardiotoxic 
agent. 
The authors wish to express their thanks to Dr. Solomon Garb of the Department of 
Pharmacology, Comer University Medical College, for the use of the Langendorff peffu- 
sion apparatus and for helpful advice throughout these studies. 
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